Serial 98360616
Live / Applied — First extension granted (statement of use) (as of 13 Nov 2025)
What this means for you
Not registered yet, but its 17 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98360616
- Mark type
- Design / logo
- Filed
- 17 Jan 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; Providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; on-line information services, namely, providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 1 GRANTED
- 06 Nov 2025 — SOU EXTENSION 1 FILED
- 06 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2025 — CORRECTED NOA E-MAILED
- 05 Nov 2025 — DIVISIONAL PROCESSING COMPLETE
- 21 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 04 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION